Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Debt / NOTE 2.875% 2/1
-
Number of holders
-
19
-
Total 13F principal, excl. options
-
259,426,607
-
Principal change
-
+5,165,000
-
Total reported value, excl. options
-
$282,455,513
-
Value change
-
+$356,625
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$1.08
Significant Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 as of Q1 2025
22 filings reported holding 19459JAC8 - COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 as of Q1 2025.
COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 has 19 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $259,426,607 of principal
.
Largest 10 bondholders include Linden Advisors LP ($112,550,000 of principal), LAZARD ASSET MANAGEMENT LLC ($34,500,000 of principal), WHITEBOX ADVISORS LLC ($33,200,000 of principal), BNP PARIBAS FINANCIAL MARKETS ($20,911,000 of principal), SILVERBACK ASSET MANAGEMENT LLC ($12,800,000 of principal), Polar Asset Management Partners Inc. ($10,000,000 of principal), Walleye Capital LLC ($7,050,000 of principal), ARISTEIA CAPITAL, L.L.C. ($6,000,000 of principal), Jump Financial, LLC ($6,000,000 of principal), and SSI INVESTMENT MANAGEMENT LLC ($3,850,000 of principal).
This table shows the top 19 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.